Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(11)
Jennifer B. Jacob
3
Wei-Zen Wei
2
Olga Radkevich-Brown
2
Henry HQ Heng
1
Richard F. Jones
1
Journals
(2)
CANCER IMMUNOL IMMUNOTHER
2
CANCER RES
1
Keywords
(17)
Embed
Subscribe
Academic
Authors
Paula J. Whittington
Paula J. Whittington,Oncology,Immunology
Edit
Paula J. Whittington
Publications:
3
|
Citations:
8
Fields:
Oncology
,
Immunology
View FAQ about top research areas and Fields of study
Collaborated with
11 co-authors
from 2008 to 2009
|
Cited by
49 authors
Cumulative
Annual
Sort by:
Publications
(3)
BibTeX
|
RIS
|
RefWorks
Download
Her2 DNA versus cell vaccine: immunogenicity and anti-tumor activity
(
Citations: 2
)
Paula J. Whittington
,
Olga Radkevich-Brown
,
Jennifer B. Jacob
,
Richard F. Jones
,
Amy M. Weise
,
Wei-Zen Wei
Journal:
Cancer Immunology Immunotherapy - CANCER IMMUNOL IMMUNOTHER
, vol. 58, no. 5, pp. 759-767, 2009
DNA Vaccination Controls Her2+ Tumors that Are Refractory to Targeted Therapies
(
Citations: 4
)
P. J. Whittington
,
M. P. Piechocki
,
H. H. Heng
,
J. B. Jacob
,
R. F. Jones
,
J. B. Back
,
W.-Z. Wei
Journal:
Cancer Research - CANCER RES
, vol. 68, no. 18, pp. 7502-7511, 2008
The “A, B and C” of Her2 DNA vaccine development
(
Citations: 2
)
Wei-Zen Wei
,
Jennifer Jacob
,
Olga Radkevich-Brown
,
Paula Whittington
,
Yi-chi M. Kong
Journal:
Cancer Immunology Immunotherapy - CANCER IMMUNOL IMMUNOTHER
, vol. 57, no. 11, pp. 1711-1717, 2008
Sort by:
Citations
(8 times by 7 publications)
Adjuvant effect of HER2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER2/neu antibody therapy for well-established breast tumors in HER2/neu transgenic mice
Y Chen
,
Y Xie
,
T Chan
,
A Sami
,
S Ahmed
,
Q Liu
,
J Xiang
Journal:
Cancer Gene Therapy
, vol. 18, no. 7, pp. 489-499, 2011
Comparative study of four failure criteria for intact bedded rock salt
X.-Y. Liu
,
L.-J. Ma
,
S.-N. Ma
,
X.-W. Zhang
,
L. Gao
Journal:
International Journal of Rock Mechanics and Mining Sciences - INT J ROCK MECH MINING SCI
, vol. 48, no. 2, pp. 341-346, 2011
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
(
Citations: 12
)
Zhujun Jiang
,
Eric D. Mortenson
,
Liufu Deng
,
Olga Radkevich-Brown
,
Xuanming Yang
,
Husain Sattar
,
Yang Wang
,
Nicholas K. Brown
,
Mark Greene
,
Yang Liu
,
Jie Tang
,
Shengdian Wang
http://academic.research.microsoft.com/io.ashx?type=5&id=36524223&selfId1=26101303&selfId2=0&maxNumber=12&query=
Journal:
Cancer Cell
, vol. 18, no. 2, pp. 160-170, 2010
Vaccination with a plasmid DNA encoding HER2/neu together with low doses of GM-CSF and IL2 in patients with metastatic breast carcinoma: a pilot clinical trial
(
Citations: 4
)
Håkan Norell
,
Isabel Poschke
,
Jehad Charo
,
Wei Z Wei
,
Courtney Erskine
,
Marie P Piechocki
,
Keith L Knutson
,
Jonas Bergh
,
Elisabet Lidbrink
,
Rolf Kiessling
Journal:
Journal of Translational Medicine - J TRANSL MED
, vol. 8, no. 1, pp. 53-11, 2010
A liposome-based platform, VacciMax ®, and its modified water-free platform DepoVax™ enhance efficacy of in vivo nucleic acid delivery
(
Citations: 3
)
Mohan Karkada
,
Genevieve M. Weir
,
Tara Quinton
,
Antar Fuentes-Ortega
,
Marc Mansour
Journal:
Vaccine
, vol. 28, no. 38, pp. 6176-6182, 2010
Comments